Importantly, PAX7 target gene score repression progresses in FSHD patient muscle over a year, a unique feature not achieved by DUX4, DUX4 target gene expression or non‐transcriptomic markers (Banerji, 2020). The gene discussed is PAX7; the disease is Facioscapulohumeral dystrophy.